Q-omics provides the consensus-scored RN7SKP255 profile across patient tissues and cancer cell-line models. RN7SKP255 expression is associated with patient survival in 18 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, RN7SKP255 is differentially expressed in 3, with the highest sampling consensus in COAD. Additionally, RN7SKP255 RNA expression shows 8,109 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight HNSC, COAD, and LSCC as cancer lineages where RN7SKP255 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RN7SKP255 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RN7SKP255 survival associations across molecular data types. RN7SKP255 RNA expression shows survival associations in the most cancer types (18). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RN7SKP255 RNA expression–survival associations across cancer types. High RN7SKP255 expression shows unfavorable associations in HNSC, LUSC, KICH, KIRC, LUAD and BRCA. The HNSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify HNSC as the clearest survival context for RN7SKP255 RNA expression.
This table summarizes RN7SKP255 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for RN7SKP255. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RN7SKP255 shows higher tumor expression in COAD, LUAD and KICH. The COAD box plot shows higher RN7SKP255 RNA expression in tumor versus normal tissue (log2 FC = +0.171, t-test p = .025).
This table shows molecular features associated with RN7SKP255 in patient tissues and cancer cell lines. In patient samples, RN7SKP255 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
